Locksley Resources (ASX: LKY) hits 99.5% purity antimony trioxide milestone, opening U.S. defense supply chain pathway
How Accenture is using Google Cloud and Wiz to close security blind spots in modern multi-cloud infrastructure
Read More 3 minute read Pharma Industry News Pasithea Therapeutics advances cancer trial after positive safety review of PAS-004 Pasithea Therapeutics Corp. (NASDAQ: KTTA) has reached a significant milestone in its Phase 1 clinical trial of PAS-004,… byPallavi MadhirajuFebruary 5, 2025